SEMINAR: Seminar

Shanghai Personal Biotechnology Co. Ltd. (hereinafter referred to as “Personalbio”) was established in 2011. Headquartered in Shanghai, Personalbio owns high-throughput sequencing platforms including Illumina MiSeq, HiSeq 2500, NextSeq 500, X-ten, NoraSeq and PacBio RS II & Sequel. Led and supported by experts from national and international institutions, Personalbio provides services including next generation sequencing, genetic testing, product development and more. Personalbio has been building a series of personal gene examination packages to improve people’s health management capability and quality of life. Using the Illumina sequencing platforms and reagent certified by FDA, Personalbio collects saliva sample from clients, extract DNA to analyze genetic information. The information is then processed through the internationally recognized genome database (OMIM, NCBI, UCSC etc.), checked with professional research literatures and international norms and standards (NCI, FDA, ACMG etc.). Based on these analyses, Personalbio is able to provide predictions of health risks and advice accordingly for clients at the genetic level. Personalbio has collaboration partners throughout China and is now keen to seek international collaboration.